Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Armand

Showing results (91-100 of 240) with videos related to

Pageof 24
Sort By:
Seminars in Oncology|October 26, 2000
Oxaliplatin in colorectal cancer: an overviewJ P Armand, V Boige, E Raymond, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1987
Excretion of doxifluridine catabolites in human bile assessed by 19F NMR spectrometryR Martino, J Bernadou, M C Malet-Martino, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1985
Release of fluoride ion from 5'-deoxy-5-fluorouridine, an antineoplastic fluoropyrimidine, in humansR Martino, A Lopez, M C Malet-Martino, et al.
Rapid Communications in Mass Spectrometry : RCM|January 1, 1995
Paclitaxel metabolites in human plasma and urine: identification of 6 alpha-hydroxytaxol, 7-epitaxol and taxol hydrolysis products using liquid chromatography/atmospheric-pressure chemical ionization mass spectrometryI Royer, P Alvinerie, J P Armand, et al.
Journal of Clinical Pharmacology|June 1, 1995
Pressor effect of oral tyramine during treatment with befloxatone, a new reversible monoamine oxidase-A inhibitor, in healthy subjectsA Patat, I Berlin, G Durrieu, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Tumour necrosis factor-alpha plasma levels after flavone acetic acid administration in man and mouseG G Chabot, D Branellec, A Sassi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
Pharmacokinetics and metabolism of 4'-iodo-4'-deoxy-doxorubicin in humansJ Robert, J P Armand, S Huet, et al.
La Nouvelle Presse Medicale|April 22, 1978
[Rise in alpha 1-fetoproteins in alcoholic hepatitis]J Boyer, P Armand, A Ben Bouali, et al.
Anti-Cancer Drugs|January 12, 2000
Clinical advances with topoisomerase I inhibitors in gastrointestinal malignanciesJ P Armand, D Cunningham, E van Cutsem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patientsD Abigerges, G G Chabot, J P Armand, et al.
Pageof 24

Showing results (91-100 of 240) with videos related to

Sort By:
Pageof 24
Seminars in Oncology|October 26, 2000
Oxaliplatin in colorectal cancer: an overviewJ P Armand, V Boige, E Raymond, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1987
Excretion of doxifluridine catabolites in human bile assessed by 19F NMR spectrometryR Martino, J Bernadou, M C Malet-Martino, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1985
Release of fluoride ion from 5'-deoxy-5-fluorouridine, an antineoplastic fluoropyrimidine, in humansR Martino, A Lopez, M C Malet-Martino, et al.
Rapid Communications in Mass Spectrometry : RCM|January 1, 1995
Paclitaxel metabolites in human plasma and urine: identification of 6 alpha-hydroxytaxol, 7-epitaxol and taxol hydrolysis products using liquid chromatography/atmospheric-pressure chemical ionization mass spectrometryI Royer, P Alvinerie, J P Armand, et al.
Journal of Clinical Pharmacology|June 1, 1995
Pressor effect of oral tyramine during treatment with befloxatone, a new reversible monoamine oxidase-A inhibitor, in healthy subjectsA Patat, I Berlin, G Durrieu, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Tumour necrosis factor-alpha plasma levels after flavone acetic acid administration in man and mouseG G Chabot, D Branellec, A Sassi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
Pharmacokinetics and metabolism of 4'-iodo-4'-deoxy-doxorubicin in humansJ Robert, J P Armand, S Huet, et al.
La Nouvelle Presse Medicale|April 22, 1978
[Rise in alpha 1-fetoproteins in alcoholic hepatitis]J Boyer, P Armand, A Ben Bouali, et al.
Anti-Cancer Drugs|January 12, 2000
Clinical advances with topoisomerase I inhibitors in gastrointestinal malignanciesJ P Armand, D Cunningham, E van Cutsem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patientsD Abigerges, G G Chabot, J P Armand, et al.
Pageof 24